Phenytoin Sodium Capsule, Extended Release
NDC 57664-808
Product Information
Phenytoin Sodium is a ANDA-approved product labeled by Sun Pharmaceutical Industries, Inc.. This medication is typically used as a anti-epileptic agent [epc]. It is supplied as a orange capsule, extended release for oral administration. This product entry covers the primary NDC 57664-808 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
SUN808
Code Structure Chart
Product Details
What is NDC 57664-808?
What are the uses of this product?
What are Active Ingredients of this product?
- PHENYTOIN SODIUM 100 mg/1 - An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- PHENYTOIN SODIUM (UNII: 4182431BJH)
- PHENYTOIN (UNII: 6158TKW0C5) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- SUCROSE (UNII: C151H8M554)
- HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- TALC (UNII: 7SEV7J4R1U)
- BENZYL ALCOHOL (UNII: LKG8494WBH)
- BUTYLPARABEN (UNII: 3QPI1U3FV8)
- D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)
- EDETATE CALCIUM DISODIUM (UNII: 25IH6R4SGF)
- FD&C RED NO. 3 (UNII: PN2ZH5LOQY)
- GELATIN, UNSPECIFIED (UNII: 2G86QN327L)
- METHYLPARABEN (UNII: A2I8C7HI9T)
- PROPYLPARABEN (UNII: Z8IX2SC1OH)
- SODIUM LAURYL SULFATE (UNII: 368GB5141J)
- SODIUM PROPIONATE (UNII: DK6Y9P42IN)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 855671 - phenytoin sodium 100 MG Extended Release Oral Capsule
- RxCUI: 855671 - DPH sodium 100 MG Extended Release Oral Capsule
Which are the Pharmacologic Classes of this product?
- Anti-epileptic Agent - [EPC] (Established Pharmacologic Class)
- Cytochrome P450 1A2 Inducers - [MoA] (Mechanism of Action)
- Cytochrome P450 2B6 Inducers - [MoA] (Mechanism of Action)
- Cytochrome P450 2C19 Inducers - [MoA] (Mechanism of Action)
- Cytochrome P450 2C8 Inducers - [MoA] (Mechanism of Action)
- Cytochrome P450 2C9 Inducers - [MoA] (Mechanism of Action)
- Cytochrome P450 2D6 Inducers - [MoA] (Mechanism of Action)
- Cytochrome P450 3A Inducers - [MoA] (Mechanism of Action)
- Decreased Central Nervous System Disorganized Electrical Activity - [PE] (Physiologic Effect)
* Please review the full disclaimer at the bottom of this page.
Patient Education
Phenytoin
Phenytoin is used to control certain type of seizures, and to treat and prevent seizures that may begin during or after surgery to the brain or nervous system. Phenytoin is in a class of medications called anticonvulsants. It works by decreasing abnormal electrical activity in the brain.
[Learn More]
* Please review the full disclaimer at the bottom of this page.